The Human Operating Manual

Therapy Time

Contents

I. What Therapy Is, and What It Isn’t

II. The Brief History

III. The Common Factors Research

IV. The Major Therapeutic Approaches

V. Where Modality Differences Do Matter

VI. Pharmacological Treatment

VII. Psychedelic-Assisted Therapy

VIII. How to Choose a Therapist

IX. What Good Therapy Looks Like

X. The Warning Signs

XI. When Therapy Isn’t Working

XII. The Industry Critiques

XIII. Specific Conditions: What the Research Supports

XIV. Cross-Links

I. What Therapy Is, and What It Isn’t

Therapy gets used to mean too many different things. Some treat it as a luxury for people with too much time and money. Some treat it as a cure for problems. Some treat it as friendship-for-hire. Some treat it as the only solution for any difficulty. Each of these misreads what therapy is and what it can do.

 

Therapy is a specific kind of professional relationship organised around a specific kind of work: examining the patterns that produce difficulty in someone’s life and developing capacities or shifts that reduce that difficulty. The relationship is asymmetric (the therapist’s role is to support the client’s work, not the reverse) and structured (it has time limits, professional boundaries, and goals).

 

Therapy works for some things, partially for others, and not at all for some. The conditions where it works best are those where psychological patterns are the primary problem and where developing new patterns is the primary solution. Depression, anxiety, trauma responses, relationship difficulties, identity struggles, and the broader category of emotional and behavioural patterns that someone wants to shift all fit here.

 

Therapy works less well where the primary problem is not psychological. Severe poverty does not yield to therapy. Severe medical illness does not yield to therapy. Acute psychosis does not yield to therapy (though therapy can support psychiatric treatment). Personality patterns that the client does not want to change do not yield to therapy. Most importantly, therapy cannot fix relationships or other people; it can only support the client’s own work.

 

What therapy is not:

  • Not friendship: A friend who listens well is valuable. A therapist does something different. The professional relationship has boundaries that allow specific work to happen which would be inappropriate in friendship. The relationship is also paid, time-limited, and oriented toward the client’s work rather than mutual exchange.
  • Not advice-giving: Some forms of therapy involve more direction than others, but even directive approaches do not work primarily by telling the client what to do. The work happens through the client developing their own understanding, capacities, and choices. Therapists who primarily give advice are usually doing it wrong.
  • Not a guaranteed fix: Some people get better through therapy. Some get modestly better. Some do not get better. The variance depends on the condition, the fit with the therapist, the client’s engagement, and luck. The framing of therapy as guaranteed solution sets people up for disappointment.
  • Not a substitute for the rest of life: Therapy can support but not replace adequate sleep, food, movement, relationships, purpose, and the broader substrate covered in Part I. Trying to therapy one’s way through severe deficits in these is rarely successful.
  • Not appropriate for everything that troubles you: Some difficulties are normal responses to difficult situations. Grief at loss does not require therapy unless it becomes pathological. Sadness about real losses does not require treatment. The medicalisation of ordinary difficulty has its own costs.

 

II. A Brief History

How therapy became what it is.

  • The Freudian beginning (1890s-1930s): Sigmund Freud developed psychoanalysis from his work with patients presenting hysterical symptoms in late 19th century Vienna. The framework involved bringing unconscious material into conscious awareness through free association, dream analysis, and examination of the transference relationship between patient and analyst. The original method took years and was accessible mainly to wealthy patients. Many specific Freudian claims have not held up; the broader insight that unconscious processes shape behaviour and that examining them therapeutically can produce change has persisted.
  • The post-Freudian splits (1920s-1950s): Multiple schools developed from and against Freud. Adler emphasised social context and inferiority feelings. Jung developed analytical psychology with its archetypes and collective unconscious. Karen Horney challenged Freud’s views on women. Erik Erikson developed psychosocial development across the lifespan. Object relations theorists (Klein, Winnicott, Fairbairn) emphasised early relational patterns. Each tradition has continued with its own practitioners.
  • Behaviorism and behavioural therapy (1920s-1960s): Behavioural approaches developed alongside and against psychoanalysis. Joseph Wolpe’s systematic desensitisation for phobias. B.F. Skinner’s broader behavioural framework. Behavioural therapy focused on observable behaviour rather than internal experience, with techniques drawn from learning theory.
  • The humanistic movement (1950s-1970s): Carl Rogers developed person-centred therapy, emphasising unconditional positive regard, empathic understanding, and congruence. Abraham Maslow developed his hierarchy of needs and the concept of self-actualisation. Fritz Perls developed Gestalt therapy. The humanistic movement emphasised the inherent capacity of people for growth and the therapeutic relationship as the primary vehicle.
  • Cognitive therapy (1960s-1970s): Aaron Beck, originally trained as a psychoanalyst, developed cognitive therapy from his observation that depression involved characteristic patterns of distorted thinking. Albert Ellis developed rational-emotive behaviour therapy with a similar focus on cognition. The cognitive approaches integrated with behavioural approaches to become cognitive behavioural therapy (CBT), which has become the most researched and most widely practised therapeutic approach.
  • The third wave (1990s-2010s): Mindfulness-based and acceptance-based approaches developed alongside traditional CBT. Marsha Linehan’s dialectical behaviour therapy (DBT) integrated CBT with mindfulness and dialectics for borderline personality disorder. Steven Hayes developed acceptance and commitment therapy (ACT). Zindel Segal, Mark Williams, and John Teasdale developed mindfulness-based cognitive therapy (MBCT). Compassion-focused therapy (Paul Gilbert) and others followed.
  • The somatic and trauma turn (1990s-present): Bessel van der Kolk’s work on trauma, Peter Levine’s somatic experiencing, Pat Ogden’s sensorimotor psychotherapy, Francine Shapiro’s EMDR (eye movement desensitisation and reprocessing), and Stephen Porges’s polyvagal-influenced approaches focused on the body’s role in trauma and the limits of purely cognitive approaches for trauma treatment. The work has been important even where specific theoretical claims (particularly polyvagal theory) have come under challenge.
  • Internal Family Systems (1980s onward): Richard Schwartz developed IFS from his work with eating disorder clients. The framework treats the psyche as containing multiple “parts” with their own perspectives and motivations, with the work involving developing relationships between these parts and the “Self” that can lead them. IFS has accumulated a following and a developing evidence base.
  • The current landscape: Multiple approaches coexist with varying levels of evidence. CBT and its variants have the largest research base. Psychodynamic approaches have evidence for longer-term work. Behavioural and exposure-based approaches dominate for specific anxiety disorders. Trauma-focused approaches have developed alongside the recognition that trauma is more prevalent than was understood. Integration is increasingly common; many therapists work across approaches rather than within a single school.

 

III. The Common Factors Research

One of the more important findings in therapy outcome research: when different approaches are compared head-to-head for the same conditions, they produce roughly similar outcomes when delivered competently. This is the Dodo Bird Verdict, named after the dodo in Alice in Wonderland who declared after a race that “everybody has won and all must have prizes.”

 

The finding has been replicated across multiple meta-analyses going back to the 1970s. The Wampold and Imel work on the contextual model has been the most systematic articulation. Their position: what produces therapy outcomes is not primarily the specific techniques but the common factors that operate across approaches.

 

The common factors include:

  • The therapeutic relationship: The quality of the alliance between client and therapist accounts for more variance in outcomes than any specific technique. A client who trusts and feels understood by their therapist tends to improve regardless of the modality.
  • The therapist’s competence: Differences between individual therapists within an approach are larger than differences between approaches. A skilled therapist in a less effective approach often outperforms a poor therapist in a more effective approach. Some therapists are reliably better than others; the patterns of what makes for effective therapists are partially understood.
  • Client factors: What the client brings to therapy (motivation, resources, social support, severity of difficulty) accounts for the largest share of variance in outcomes, more than therapist or technique factors.
  • A coherent rationale: Any therapy that provides a credible framework for understanding the difficulty and a credible path to addressing it produces benefits beyond what control conditions produce. The credibility of the framework matters more than its accuracy.
  • Activated hope: Therapy that activates the client’s hope and engagement produces better outcomes. This is one mechanism the placebo effect operates through; therapy includes its own placebo-like activation of expectation and engagement.

 

The Dodo Bird Verdict has been disputed. Researchers committed to specific modalities argue that head-to-head comparisons have often been methodologically inadequate, that the verdict obscures real differences in outcomes for specific conditions, and that the common factors operate through the specific techniques rather than independently of them. The dispute is genuine.

 

For most clients with most conditions, finding a competent therapist with whom they have a good working relationship is more important than finding the specific evidence-based modality for their condition. For some clients with specific conditions (covered below), the modality choice does affect outcomes significantly.

 

IV. The Major Therapeutic Approaches

The approaches the client is most likely to encounter.

 

Cognitive Behavioural Therapy (CBT)

The most researched and widely practised approach. The framework treats psychological difficulty as involving distorted thinking patterns and maladaptive behaviours, with the work involving identifying and modifying these.

  • What it does: Structured, time-limited, focused on specific symptoms and patterns. Homework between sessions. Concrete techniques including cognitive restructuring, behavioural experiments, exposure, and behavioural activation.
  • What it works for: Depression, anxiety disorders, OCD (with exposure and response prevention), specific phobias, panic disorder, social anxiety, insomnia, and other conditions where specific patterns can be identified and modified. The evidence base is the strongest of any therapy approach.
  • Limits: Less effective for conditions where the difficulty is more diffuse, where trauma is the primary issue, where personality patterns require longer work, or where the client’s difficulty is fundamentally about meaning and purpose rather than specific cognitive patterns.

 

Dialectical Behaviour Therapy (DBT)

Marsha Linehan’s development of CBT specifically for clients with severe emotional dysregulation, originally for borderline personality disorder.

  • What it does: Combines cognitive and behavioural techniques with mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness skills. Includes individual therapy, skills training group, phone coaching for crisis support, and therapist consultation team. Highly structured and intensive.
  • What it works for: Borderline personality disorder is the original target and remains the strongest indication. The DBT skills also help with eating disorders, substance use disorders, treatment-resistant depression, and other conditions involving severe emotional dysregulation.
  • Limits: Demanding for clients (weekly individual plus group, daily skills practice). The DBT model is not always available in less specialised treatment contexts; the full programme requires substantial resources.

 

Acceptance and Commitment Therapy (ACT)

Steven Hayes’s third-wave approach that integrates acceptance, mindfulness, and values-based action.

  • What it does: Less focused on changing thought content than CBT. More focused on changing the relationship to thoughts (defusion), increasing acceptance of difficult internal experience, clarifying values, and committing to action aligned with values regardless of internal difficulty.
  • What it works for: Chronic pain, depression, anxiety, work stress, broader life satisfaction issues. The evidence base is developing and shows comparable effectiveness to CBT for many conditions.
  • Limits: The values-clarification work assumes some capacity for it; severely depressed or dysregulated clients may need stabilisation first. The defusion techniques can feel counterintuitive; some clients prefer the more direct cognitive change approach of traditional CBT.

 

Psychodynamic and Psychoanalytic Therapy

The descendant tradition of Freud’s work, in various forms.

  • What it does: Examines unconscious patterns, defence mechanisms, the transference relationship, early developmental experiences, and how these shape current functioning. Less structured and longer-term than CBT, typically. Open-ended exploration rather than focused symptom reduction.
  • What it works for: Longer-term personality patterns, complex emotional difficulties, identity questions, relational patterns that recur across life, and broader meaning-making work. The evidence base is real but smaller than CBT’s, partly because the work is harder to operationalise for research.
  • Limits: Length and cost are barriers. Some practitioners over-rely on specific Freudian claims that have not held up. The intensive work requires therapist skill; less skilled practitioners produce more variable outcomes.

 

EMDR

Francine Shapiro’s eye movement desensitisation and reprocessing approach, originally developed for trauma.

  • What it does: Combines elements of exposure therapy with bilateral stimulation (originally eye movements, now also tapping or sounds) while the client recalls traumatic material. The bilateral stimulation appears to facilitate processing of stuck traumatic memories.
  • What it works for: Single-incident trauma has the strongest evidence base. Complex trauma is more contested but EMDR is one of the major approaches. PTSD broadly.
  • Limits: Less effective for complex developmental trauma in the absence of broader treatment. Some practitioners overreach the evidence base, applying EMDR to conditions where its efficacy is less established. The mechanism remains partly unclear; the effectiveness is real even where the mechanism is debated.

 

Internal Family Systems (IFS)

Richard Schwartz’s approach treating the psyche as containing multiple parts.

  • What it does: Identifies different “parts” of the client (managers, exiles, firefighters in IFS terminology) and the Self that can lead them. Work involves developing relationships between parts and Self, unburdening exiled parts of traumatic material, and unblending parts from the Self so the Self can lead.
  • What it works for: Trauma, complex psychological patterns, eating disorders, addiction. The evidence base is developing; outcome studies have been promising but the modality is less rigorously researched than CBT.
  • Limits: The “parts” language can feel artificial to some clients. The model’s specific theoretical claims (the universality of multiplicity, the inherent goodness of Self) are not empirically established and are more philosophical commitments than research findings. Less rigorous practitioners can use IFS in ways that lack therapeutic structure.

 

Somatic and Trauma-Focused Approaches

Multiple approaches focused on the body’s role in trauma and emotional difficulty.

  • Somatic Experiencing (Peter Levine): Works with the body’s incomplete fight-flight-freeze responses to trauma, allowing them to complete without overwhelming the client.
  • Sensorimotor Psychotherapy (Pat Ogden): Integrates body-focused work with cognitive and emotional processing.
  • Trauma-Focused CBT (Judith Cohen and others): Specific protocol for trauma, particularly with children and adolescents.
  • Prolonged Exposure (Edna Foa): Direct exposure to trauma memories and reminders to allow extinction of conditioned fear responses.
  • Cognitive Processing Therapy (Patricia Resick): Focuses on cognitive patterns around the trauma rather than direct exposure.
  • What they work for: Trauma in its various forms. The specific approach depends on trauma type, severity, and client preference. The evidence base is strongest for prolonged exposure and EMDR for single-incident PTSD.
  • Limits: Complex developmental trauma (early sustained relational trauma) responds less well to single-modality approaches and typically requires longer, more integrative treatment. The “trauma” framing has been expanded in popular discourse to cover difficulties that may not be trauma in the technical sense; treating ordinary difficulty as trauma is its own problem.

 

Humanistic and Person-Centred

Carl Rogers’s framework and its descendants.

  • What it does: Focuses on unconditional positive regard, empathic understanding, and congruence from the therapist. Less directive than CBT or psychodynamic; the work follows the client’s lead.
  • What it works for: Clients who benefit from supportive exploration. Issues of self-acceptance, identity, and meaning. Often combined with other approaches in practice.
  • Limits: Less structured; outcomes depend more on therapist skill and client engagement. Less effective for severe symptoms requiring directive intervention.

 

Emotionally Focused Therapy (EFT)

Sue Johnson’s attachment-based couples therapy, also adapted for individual work.

  • What it does: Identifies the attachment patterns underlying relationship distress, helps couples recognise the cycle of disconnection, and supports the development of secure connection.
  • What it works for: Couples therapy with the strongest evidence base. The Johnson et al. outcome studies show improvement rates with durable effects.
  • Limits: Requires both partners to engage. Less effective when one partner has decided to leave the relationship or when severe untreated issues (addiction, untreated trauma, ongoing infidelity) are present.

 

Family Systems Approaches

Multiple approaches treating the family as the unit of intervention.

  • Structural Family Therapy (Salvador Minuchin): Focuses on family structure and boundaries.
  • Strategic Family Therapy (Jay Haley): Focuses on specific interactional patterns and prescribed change.
  • Bowen Family Systems Therapy (Murray Bowen): Focuses on multigenerational patterns and differentiation of self.
  • Narrative Therapy (Michael White and David Epston): Focuses on the stories families tell about themselves and how these can be re-authored.
  • What they work for: Family conflict, children’s behavioural problems where family dynamics contribute, identified-patient framings where the family system needs reorganisation.

 

Group Therapy

Therapy conducted in groups rather than individually. Multiple modalities exist within group formats.

  • What it does: Provides therapeutic work alongside peer support and the recognition that others share similar difficulties. Allows for interpersonal learning that individual therapy cannot.
  • What it works for: Many conditions, particularly those involving shame, isolation, or specific identifiable difficulties (substance use, eating disorders, social anxiety, trauma).
  • Limits: Some clients need individual work first to build capacity for group engagement. Quality varies with group composition and facilitator skill.

 

V. Where Modality Differences Do Matter

The Dodo Bird Verdict notwithstanding, modality choice does affect outcomes for some specific conditions.

  • OCD: Exposure and Response Prevention (a CBT variant) outperforms other approaches. The evidence base is robust. Clients with OCD should typically pursue ERP-trained therapists.
  • Single-incident PTSD: Prolonged Exposure, Cognitive Processing Therapy, and EMDR all outperform less specific approaches. Trauma-focused work is recommended over general supportive therapy.
  • Borderline Personality Disorder: DBT has the strongest evidence base, though Mentalisation-Based Therapy and Transference-Focused Psychotherapy also have evidence.
  • Couples Therapy: EFT has the strongest evidence base. Gottman Method also has outcome research. The general “couples counselling” without a specific evidence-based framework produces more variable results.
  • Eating Disorders: Family-based treatment for adolescent anorexia. CBT-Enhanced for adult eating disorders. DBT for eating disorders with significant emotional dysregulation.
  • Severe Depression: Combination of CBT or interpersonal therapy with medication outperforms either alone for severe depression. MBCT for prevention of relapse.
  • Substance Use Disorders: Motivational Interviewing for engagement. CBT, contingency management, and 12-step facilitation all have evidence bases. Combined approaches typically outperform single approaches.
  • Chronic Pain: ACT has the strongest evidence base among psychological approaches. CBT for chronic pain also effective.
  • Phobias: Brief exposure-based treatment outperforms other approaches for specific phobias. Often achievable in a small number of sessions.

 

For these specific conditions, the modality choice does shift outcomes. For broader difficulties without these specific diagnoses, the choice of therapist matters more than the choice of modality.

 

VI. Pharmacological Treatment

Medication is appropriate for some psychiatric conditions and warrants engagement with a qualified prescriber.

  • Antidepressants (SSRIs and SNRIs): The most prescribed psychiatric medications globally. The evidence base has been revised over the past two decades. The Cipriani et al. 2018 network meta-analysis confirmed that antidepressants outperform placebo for major depression at population level, with effect sizes that are modest (NNT around 8 for response). The benefit is larger for severe depression and smaller for mild to moderate depression. Side effects are common including sexual dysfunction, emotional blunting, and weight changes. Discontinuation can be difficult; the Davies and Read 2019 review documented that withdrawal effects are more common and severe than was previously acknowledged.
  • Anti-anxiety medications: Benzodiazepines (lorazepam, diazepam, clonazepam) work rapidly but produce tolerance and dependence. Generally appropriate for short-term use rather than long-term. SSRIs also work for anxiety with the medication considerations above. Buspirone is a non-addictive alternative with less robust evidence.
  • Mood stabilisers: Lithium remains the gold standard for bipolar disorder despite its side effect profile. Lamotrigine for bipolar depression. Various anticonvulsants. The evidence base for bipolar disorder treatment is strong.
  • Antipsychotics: First-line for psychotic disorders. Increasingly prescribed off-label for sleep, anxiety, and other conditions; this off-label use is poorly supported by evidence and produces side effects (metabolic syndrome, weight gain, movement disorders).
  • Stimulants: First-line for ADHD with strong evidence base. Methylphenidate (Ritalin, Concerta) and amphetamine-based medications. The overdiagnosis of ADHD in some populations has produced legitimate concerns about overprescription alongside the legitimate use for accurately diagnosed cases.
  • Other: Lithium for severe suicidality and bipolar. Ketamine and esketamine for treatment-resistant depression. Various other medications with specific indications.

 

Psychiatric medication is appropriate for some conditions and helps some people. It’s not appropriate for all distress, and the over-prescription of psychiatric medications for ordinary difficulty has produced its own problems. The choice involves trade-offs that should be discussed with a qualified prescriber. Therapy and medication are not in competition; they often work better together than either alone for moderate to severe conditions.

 

VII. Psychedelic-Assisted Therapy

The research on psychedelic-assisted therapy has expanded since approximately 2010 after decades of prohibition-driven research absence. The picture as of early 2026:

  • Psilocybin for depression: Multiple controlled trials have shown psilocybin-assisted therapy producing reductions in depression, with effect sizes larger than antidepressant medication in head-to-head studies. The Carhart-Harris and Goodwin work has been particularly influential. The treatment involves typically two or three high-dose sessions with extensive preparation and integration support. Sustained benefits at 6-12 month follow-up in many participants.
  • Psilocybin for end-of-life anxiety: Strong evidence for reductions in anxiety and depression in patients facing life-threatening illness. The work from Johns Hopkins and NYU has been the most influential.
  • MDMA-assisted therapy for PTSD: The MAPS Phase 3 trials showed improvements with MDMA-assisted therapy combined with intensive psychotherapy. However, the FDA in 2024 rejected the MDMA-PTSD application over methodological concerns including blinding difficulties (participants typically know whether they received MDMA), site issues, and concerns about adverse events. The treatment remains in development; the rejection sets back but does not eliminate the path to approval.
  • Ketamine for depression: FDA-approved esketamine (Spravato) for treatment-resistant depression. Off-label ketamine clinics have proliferated. The evidence supports rapid antidepressant effects in many patients; the duration of benefit without repeated dosing is short. Ketamine is dissociative and the experience is qualitatively different from classical psychedelics.
  • Ayahuasca and traditional contexts: Traditional use in Amazonian contexts; growing tourism use; some research on therapeutic applications. The complexity is substantial; engagement with ayahuasca outside traditional or carefully managed therapeutic contexts carries real risks.
  • LSD: Recent revival of research after the original 1950s-60s wave. Some promising results for anxiety and substance use disorders. The longer duration (8-12 hours vs psilocybin’s 4-6) creates practical challenges for therapeutic protocols.

 

Psychedelic-assisted therapy is a promising area with real evidence for specific applications, but it’s not the panacea that some popular accounts suggest. The risks are real, particularly for individuals with psychotic disorder history or active severe mental illness. The integration work after the sessions is critical to outcomes. The therapeutic context matters ; recreational use of these substances is not equivalent to therapeutic use.

 

This is an evolving area where the evidence is real, but the implementation is still being worked out. Treatment outside regulated therapeutic contexts carries risks that the popular discourse often understates. Treatment in regulated contexts shows promise for specific conditions.

 

VIII. How to Choose a Therapist

The practical work of finding therapy that fits.

  • Credentials: Look for someone with appropriate licensure in your jurisdiction. The specific credentials vary by country: psychologists, psychiatrists, social workers, counsellors, psychotherapists all have different training requirements. Licensure ensures minimum standards; it does not guarantee skill.
  • Modality match: For specific conditions where modality matters (OCD, PTSD, BPD, couples), seek therapists trained in the evidence-based approach. For broader difficulties, modality matters less than fit.
  • The first session: Most therapists offer brief consultations or accept that the first session is partly mutual assessment. Notice how you feel in the session. Did the therapist seem present and engaged? Did they ask useful questions? Did they explain how they work? Did they make you feel heard?
  • Fit indicators: The therapeutic relationship is the strongest predictor of outcomes. After two or three sessions, you should have some sense of whether this is going to work. Indicators of good fit: you feel safe enough to be honest, you feel the therapist understands you, you trust their judgement, you can disagree with them without it feeling threatening.
  • The financial question: Therapy is expensive. The cost barriers exclude many people who would benefit. Options include: sliding-scale fees (many therapists offer reduced rates), insurance coverage (varies), employee assistance programmes, university training clinics (supervised trainees at reduced rates), community mental health centres, group therapy (lower cost per session), online therapy platforms (cheaper but variable quality), and free or low-cost peer support options.
  • The duration question: Some therapy is brief and focused (CBT for specific phobia, 6-12 sessions). Some therapy is longer (psychodynamic work, multiple years). The expected duration depends on the work being done. Most people benefit most from regular sessions for at least several months; very brief therapy is appropriate for specific limited problems.

 

IX. What Good Therapy Looks Like

Indicators that the work is going somewhere useful:

  • You feel understood, even when discussing difficult material
  • The therapist seems engaged and curious about your specific experience rather than running standard responses
  • You learn things about yourself you did not previously see
  • You develop capacities or shifts you can take into the rest of your life
  • The therapist challenges you when appropriate without being harsh
  • You can disagree with the therapist and have the disagreement be useful rather than threatening
  • Your life outside therapy improves over time
  • You feel respected in the relationship
  • The therapist maintains appropriate boundaries (does not become friends with you, does not see you in inappropriate contexts, does not engage romantically or sexually)
  • You can talk about how the therapy itself is going

 

The improvements are typically slow and uneven. Periods of progress alternate with periods of difficulty. The overall trajectory across months should be positive even when specific weeks feel hard.

 

X. The Warning Signs

Indicators that the work is not going well or that the therapist is problematic:

  • The therapist talks more about themselves than about you
  • You feel worse after sessions for sustained periods (not just temporary difficulty)
  • The therapist seems judgemental or dismissive of your experience
  • The therapist crosses appropriate boundaries (social contact outside therapy, romantic or sexual interest, friendship-like relationship, financial entanglements)
  • The therapist makes you feel responsible for their feelings
  • The therapist insists you stay in therapy when you’ve expressed doubts
  • The therapist becomes the central focus of your life in unhealthy ways
  • The therapist makes claims of special powers or insights
  • The therapist breaches confidentiality
  • The therapist pressures you toward specific decisions about your life that you have not initiated
  • You’re not learning anything you did not already know after several months
  • Specific symptoms persist or worsen without acknowledgement of this

 

Bad therapy can produce harm. The cultural framing that all therapy is good and all therapists are skilled is wrong. Some therapists are reliably unhelpful or actively damaging. Recognising this and ending the relationship is a regulation skill in itself.

 

XI. When Therapy Isn’t Working

If therapy is not producing benefits after several months, several possibilities:

  • The fit is wrong: Try a different therapist before concluding that therapy doesn’t work for you. Therapeutic relationships have variance; the next therapist may produce different outcomes.
  • The modality is wrong: If you’ve been doing supportive talking therapy for a condition that warrants specific intervention (OCD, severe PTSD, eating disorder), the modality match may be the issue.
  • The conditions are wrong: Life circumstances that are themselves the source of distress (severe poverty, abusive relationship, severely toxic work environment) limit what therapy can accomplish. Sometimes the answer is changing the situation, not adapting better to it.
  • The substrate is wrong: Severe sleep deprivation, severe nutritional deficits, severe physical illness, untreated substance dependence, untreated psychiatric conditions can all block therapy from working. Address these and therapy may then be effective.
  • The engagement is wrong: Therapy requires engagement outside the session. If you’re not doing the work between sessions, the in-session work won’t be enough.
  • Medication is missing: For some conditions, therapy alone is insufficient and medication is needed alongside it. Severe depression, bipolar disorder, severe anxiety, psychotic disorders often require both.
  • Therapy isn’t the right tool: Some difficulties are not therapeutic problems. Life dissatisfaction that’s really about needing a different job. Relationship difficulty that’s really about needing to leave the relationship. Spiritual or existential crises that may need different forms of engagement.

 

The engagement with non-progress includes considering whether to continue, change therapist, change modality, add medication, change other conditions, or stop therapy entirely. Continuing therapy that’s not working is its own problem.

 

XII. The Industry Critiques

The therapy industry has real problems worth naming.

  • Access: Therapy is expensive and the cost excludes many people who would benefit. Insurance coverage varies. Public mental health systems are typically underfunded with long waiting lists. The people most likely to need therapy often face the largest barriers to accessing it.
  • Quality variability: Licensure ensures minimum training but does not ensure skill. Some licensed therapists are reliably unhelpful. The quality control mechanisms in most jurisdictions are inadequate; bad therapists often continue practising for years.
  • The medicalisation question: The expansion of mental health categories and the framing of ordinary distress as treatable conditions has produced more clients for the therapy industry but has also pathologised normal experience. Grief becomes “complicated grief disorder.” Worry becomes “generalised anxiety disorder.” Shyness becomes “social anxiety disorder.” The diagnostic creep has costs.
  • Cultural appropriation: Indigenous healing practices, Buddhist meditation, somatic traditions, and other approaches have been incorporated into Western therapy while the source traditions and practitioners have often not benefited proportionally. The pattern is similar to what happened with mindfulness.
  • The DSM problem: The Diagnostic and Statistical Manual continues to be the framework structuring much of mental health care. The DSM categories are partly empirically based and partly social constructs reflecting cultural assumptions about what constitutes pathology. Multiple critics including the Hearing Voices movement, mad pride advocates, and academic critics have raised legitimate concerns about specific DSM categories.
  • The pharmaceutical industry: The relationship between psychiatric treatment and pharmaceutical company funding has produced documented distortions in the research base, in clinical guidelines, and in prescribing patterns. The Robert Whitaker work and others have raised legitimate concerns that should be engaged with rather than dismissed.
  • The therapist-client power asymmetry: Therapy involves vulnerability on the client’s side and power on the therapist’s side. Most therapists handle this responsibly; the cases where they don’t can produce substantial harm. The professional protections for clients are real but imperfect.

 

Therapy is genuinely useful for many people for many conditions. The industry has real problems that should be acknowledged. The critiques should not be dismissed as anti-therapy, but neither should they be used to dismiss therapy as a whole. Both the value and the problems are real.

 

XIII. Specific Conditions: What the Research Supports

Brief summaries of evidence-based approaches for common conditions.

  • Major Depression: CBT, Interpersonal Therapy, behavioural activation, antidepressants. Combination outperforms either alone for severe depression. MBCT for relapse prevention. Exercise as adjunctive treatment. For severe treatment-resistant depression: ketamine, ECT, possibly psilocybin (in regulated trials).
  • Generalised Anxiety Disorder: CBT, ACT. SSRIs for moderate to severe cases. Mindfulness-based approaches. Lifestyle factors substantial.
  • Panic Disorder: CBT with interoceptive exposure. SSRIs. Avoid benzodiazepines for long-term treatment.
  • Social Anxiety Disorder: CBT, particularly with social exposure components. SSRIs.
  • OCD: Exposure and Response Prevention (ERP). SSRIs, often at higher doses than for depression. Combination of ERP and medication.
  • PTSD: Trauma-focused CBT, Prolonged Exposure, Cognitive Processing Therapy, EMDR. Combat-related PTSD may respond differently than other trauma. For severe treatment-resistant cases: MDMA-assisted therapy (in trials), possibly ketamine.
  • Borderline Personality Disorder: DBT, Mentalisation-Based Therapy, Transference-Focused Psychotherapy, Schema Therapy. Long-term treatment typically required. Medication has limited role.
  • Bipolar Disorder: Mood stabilisers (lithium, valproate, lamotrigine, antipsychotics). Psychoeducation. Family-focused therapy. Interpersonal and Social Rhythm Therapy.
  • Eating Disorders: Family-Based Treatment for adolescent anorexia. CBT-Enhanced for adult eating disorders. DBT for severe emotional dysregulation. Nutritional rehabilitation alongside therapy.
  • Substance Use Disorders: Motivational Interviewing. CBT. Contingency management. 12-step facilitation. Medication-assisted treatment (methadone, buprenorphine, naltrexone) for opioid use disorder. The harm reduction movement has shifted what’s considered appropriate treatment.
  • ADHD: Stimulant medication (first-line for adults and children). Behavioural interventions for children. Coaching for adults. Lifestyle factors (sleep, exercise, nutrition) substantial.
  • Couples Issues: EFT (Sue Johnson). Gottman Method. Imago. Discernment counselling for ambivalent couples.
  • Schizophrenia and Psychotic Disorders: Antipsychotic medication first-line. Cognitive Behavioural Therapy for psychosis (CBTp). Family interventions. Coordinated specialty care for first-episode psychosis. The Open Dialogue approach has shown promising outcomes in some contexts.

 

The list is not exhaustive. Specific conditions warrant deeper engagement with the research base. The reasonable position: there is more evidence-based help available for most conditions than is typically utilised, and finding the right approach for a specific condition can substantially shift outcomes.

 

XIV. Cross-Links

The broader Emotional Regulation section:

Resources

  • For the original Dodo Bird Verdict, see Luborsky, L., Singer, B., & Luborsky, L. (1975). Comparative studies of psychotherapies: is it true that “everyone has won and all must have prizes”? Archives of General Psychiatry, 32(8), 995–1008.
  • Wampold, B.E., & Imel, Z.E. (2015). The Great Psychotherapy Debate: The Evidence for What Makes Psychotherapy Work (second edition). Routledge.
  • For ERP and OCD, see Foa, E.B., Yadin, E., & Lichner, T.K. (2012). Exposure and Response (Ritual) Prevention for Obsessive-Compulsive Disorder: Therapist Guide (second edition). Oxford University Press.
  • For PTSD treatment, see Foa, E.B., Hembree, E.A., Rothbaum, B.O., & Rauch, S.A.M. (2019). Prolonged Exposure Therapy for PTSD: Emotional Processing of Traumatic Experiences (second edition). Oxford University Press.
  • For BPD treatment outcomes, see Cristea, I.A., Gentili, C., Cotet, C.D., Palomba, D., Barbui, C., & Cuijpers, P. (2017). Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis. JAMA Psychiatry, 74(4), 319–328.
  • For EFT outcome research, see Wiebe, S.A., & Johnson, S.M. (2016). A review of the research in Emotionally Focused Therapy for couples. Family Process, 55(3), 390–407.
  • For eating disorder treatment, see Fairburn, C.G. (2008). Cognitive Behavior Therapy and Eating Disorders. Guilford Press.
  • For depression treatment, see Cuijpers, P., Karyotaki, E., Weitz, E., Andersson, G., Hollon, S.D., & van Straten, A. (2014). The effects of psychotherapies for major depression in adults on remission, recovery and improvement: a meta-analysis. Journal of Affective Disorders, 159, 118–126.
  • For ACT and chronic pain, see Hughes, L.S., Clark, J., Colclough, J.A., Dale, E., & McMillan, D. (2017). Acceptance and commitment therapy (ACT) for chronic pain: a systematic review and meta-analyses. The Clinical Journal of Pain, 33(6), 552–568.
  • Cipriani, A., Furukawa, T.A., Salanti, G., et al. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet, 391(10128), 1357–1366.
  • Davies, J., & Read, J. (2019). A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: are guidelines evidence-based? Addictive Behaviors, 97, 111–121.
  • For psilocybin and depression, see Carhart-Harris, R., Giribaldi, B., Watts, R., et al. (2021). Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine, 384(15), 1402–1411.
  • For psilocybin and end-of-life anxiety, see Griffiths, R.R., Johnson, M.W., Carducci, M.A., et al. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial. Journal of Psychopharmacology, 30(12), 1181–1197.
  • For the MAPS Phase 3 trial and FDA decision, see Mitchell, J.M., Bogenschutz, M., Lilienstein, A., et al. (2021). MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine, 27(6), 1025–1033. Plus the subsequent FDA Complete Response Letter (August 2024).
  • Whitaker, R. (2010). Anatomy of an Epidemic: Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America. Crown.